The Following Appears on asia.nikkei.com
Japanese printer maker targets capacity equivalent to 100m COVID shots by 2025
TOKYO — Ricoh will acquire U.S.-based biotechnology startup Elixirgen Scientific as early as July in a push to turn messenger RNA technology into a core business, Nikkei has learned.
Click Here to Read the Rest
SOURCE Nikkei
Ricoh USA, Inc. Named to ChannelE2E Top 100 Vertical Market MSPs: 2022 Edition